Valiant Laboratories Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹20(14.29%)
Premium (ELP)
Valiant Laboratories Limited's completed its IPO journey with a successful listing on NSE, BSE on Oct 06, 2023. The public offering mobilized 1,15,56,000 Shares in total capital, comprising 1,15,56,000 Shares in fresh equity.
The offering was conducted within the price band of ₹133 to ₹140, with minimum application lots of 105 shares. Investor participation during the Sep 27, 2023 to Oct 03, 2023 subscription window determined the final allocation pattern.
The basis of allotment was announced on Oct 04, 2023, finalizing share distribution to successful applicants. The listing represents a significant corporate development, providing the company with enhanced visibility and access to public capital markets.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Incorporated in 1980, Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (API) manufacturing company in India primarily focused on producing Paracetamol. The company operates a manufacturing facility in Palghar, Maharashtra, spread across 2,000 sq. meters with a total installed annual capacity of 9,000 MT. Valiant Laboratories also has an in-house R&D facility equipped with an analytical laboratory and infrastructure to support development and improvement of existing products, strengthening its capabilities in the pharmaceutical ingredient space.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
NA
NA
- Shantilal Shivji Vora
- Dhanvallabh Ventures LLP (DVL)
Valiant Laboratories Limited
Link Intime India Private Limited